Practical treatment strategies for patients with Alzheimer's disease

Journal of Family Practice

Volumn 56, Issue 12 SUPPL., 2007, Pages

  Christensen, Daniel D ^a   Lin, Peter ^b  

^a University of Utah Neuropsychiatric Institute   (United States)

^b CANADIAN HEART RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; DONEPEZIL; GALANTAMINE; MEMANTINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; TACRINE; TRAZODONE; VALPROIC ACID;

AGING; AGITATION; ALZHEIMER DISEASE; BRADYCARDIA; BRAIN ATROPHY; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC IMAGING; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; HUMAN; IMAGE ANALYSIS; MINI MENTAL STATE EXAMINATION; MORNING DOSAGE; NAUSEA; PSYCHOLOGIC TEST; REVIEW; SIDE EFFECT; VOMITING; WEAKNESS; WEIGHT REDUCTION;

AGE FACTORS; AGED; ALZHEIMER DISEASE; AUTOPSY; CAREGIVERS; CHOLINESTERASE INHIBITORS; DISEASE PROGRESSION; FAMILY PRACTICE; FATAL OUTCOME; HUMANS; MALE; MASS SCREENING; MENTAL STATUS SCHEDULE; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PSYCHOMOTOR AGITATION; RESEARCH; SOCIAL SUPPORT;

EID: 37349057498     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Alzheimer's Association. 2007 Alzheimer's Disease Facts and Figures. http://www.alz.org/national/documents/Report_2007FactsAndFigures.pdf. Accessed October 12, 2007.
2. Hebert LE, Scherr PA, Scherr JL, et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119-1122.
3. National Institute of Aging. 2005-2006 Progress report on Alzheimer's disease. US National Institutes of Health. http://www.nia.nih.gov/Alzheimer's/ Publications/AADProgress. Accessed October 12, 2007.
4. American Academy of Family Physicians, April 2006 Survey. Clinically-related continuing medical education needs expressed by family physicians, April 2006. Table 30a. http://www.aafp.org/online/en/home/aboutus/ specialty/facts/30.html. Accessed October 12, 2007.
5. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
6. Boller F, Barba GD. Neuropsychological tests in Alzheimer's disease. Aging Clin Exp Res. 2001;13:210-220.
7. Cummings JL, Frank JC, Cherry D, et al. Guidelines for managing Alzheimer's disease: Part II. Treatment. Am Fam Physician. 2002;65:2525-2534.
8. American Psychiatric Association. Diagnostic Criteria for Dementia of the Alzheimer's Type. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000:157.
9. Ross GW, Bowen JD. The diagnosis and differential diagnosis of dementia. Med Clin North Am. 2002;86:455-476.
10. Waldemar G, Dubois B, Emre M, et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia. EFNS guideline. Eur J Neurol. 2007;14:e1-26.
11. Farlow MR, Cummings JL. Effective pharmacologic management of Alzheimer's disease. Am J Med. 2007;120:388-397.
12. Geldmacher DS. The cost benefit to health plans of pharmacotherapy for Alzheimer's disease. Manag Care. 2005;14:44-46, 49-52, 54-55.
13. Kaufer DI, Borson S, Kershaw P, et al. Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine. CNS Spectr. 2005;10:481-488.
14. Weycker D, Taneja C, Edelsberg J, et al. Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil. Curr Med Res Opin. 2007;23:1187-1197.
15. Fillit HM, Doody RS, Binasco K, et al. Recommendations for best practices in the treatment of Alzheimer's disease in managed care. Am J Geriatr Pharmocother. 2006;4(suppl A):S9-S24.
16. Geldmacher DS. Long-term cholinesterase inhibitor therapy for Alzheimer's disease: practical considerations for the primary care physician. Primary Care Companion J Clin Psychiatry. 2003;5:2251-2259.
17. Doody RS, Stevens JC, Beck C, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1154-1166.
18. Bonner LT, Peskind ER. Pharmacologic treatment of dementia. Med Clin North Am. 2002;86:657-674.
19. Wilkinson DG, Francis PT, Schwam E, et al. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging. 2004;21:453-478.
20. Boothby LA, Doering PL. Vitamin C and vitamin E for Alzheimer's disease. Ann Pharmacother. 2005;39:2073-2080.
21. Tariot PN, Farlow MR, Grossberg GT, et al for the Memantine Study Group. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial. JAMA. 2004;291:317-324.
22. Teri L, Logsdon RG, McCurry SM. Nonpharmacologic treatment of behavioral disturbance in dementia. Med Clin North Am. 2002;86:641-656.
23. National Guideline Clearinghouse. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. http://www.guideline.gov. Accessed October 12, 2007.
24. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294:1934-1943.
25. Christakis NA, Allison PD. Mortality after the hospitalization of a spouse. N Engl J Med. 2006;354:719-730.
26. Alzheimer's Foundation of America. I CAN: Investigating Caregivers' Attitudes and Needs. March 2006. http://www.alzfdn.org/surveys/ survey_full_report.doc. Accessed November 2, 2007.
27. Livingston G, Johnston K, Katona C, et al, for the Old Age Task Force of the World Federation of Biological Psychiatry. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry. 2005;162:1996-2021.
28. Christensen DD. Changing the course of Alzheimer's disease: anti-amyloid disease-modifying treatments on the horizon. Prim Care Companion J Clin Psychiatry. 2007;9:32-41.